How to Buy Trisalus Life Sciences Stock
Trisalus Life Sciences Inc
TriSalus Life Sciences, Inc. , an immunotherapy company that develops and commercializes immunotherapies for the treatment of liver and pancreatic tumors.
Trisalus Life Sciences stock last closed at $5.72, up 0% from the previous day, and has decreased 38.92% in one year. It has underperformed other stocks in the Medical Devices industry by 0.25 percentage points. Trisalus Life Sciences stock is currently +63.43% from its 52-week low of $3.50, and -44.14% from its 52-week high of $10.24.
There are currently 32.27M TLSI shares outstanding. The market value of TLSI is $184.60M. In the past 24 hours, 12,256 TLSI shares were traded.
How to Buy Trisalus Life Sciences Stock
Not sure how to invest in Trisalus Life Sciences stock? Here's how.
- Decide where to buy Trisalus Life Sciences stock: You need to pick a stock brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you figure out where to buy Trisalus Life Sciences stock.
- Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Put funds into your investment account: Choose your method of payment and add your details.
- Analyze Trisalus Life Sciences stock: The Trisalus Life Sciences ticker symbol is TLSI. Is Trisalus Life Sciences stock a good investment? Should you buy shares of TLSI? How do TLSI's underlying business fundamentals look? Do top analysts think Trisalus Life Sciences is a good buy? Why has TLSI's stock price moved recently? (Hint: Our stock market research website can help you evaluate if TLSI is a good stock to buy).
- Make your TLSI purchase: Decide if you will purchase TLSI shares at the current market price or use a limit order to purchase TLSI shares at a specific price.
- Get key alerts regarding your TLSI investment: Create a watchlist to the latest updates on your new investment in Trisalus Life Sciences stock.
Step 1: Decide where to buy Trisalus Life Sciences stock
You need a brokerage account to access the NASDAQ market and buy TLSI shares.
Our recommended brokerage: eToro
Based on our experience, eToro is the best online stock brokerage. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to world financial markets: From Tech to Healthcare, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've chosen the best brokerage, it's time to fill out some personal information so you are able to invest in TLSI today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to open your new brokerage account.
- Send your data by hitting the "Create Account" button. Get started with eToro today
Step 3: Put funds into your investment account
Now that you've filled out your info on one of the best stock market apps, you can securely and quickly fund your account:
Check out this video walkthrough if you need help transferring funds into your new brokerage account.
Step 4: Analyze Trisalus Life Sciences stock
After you have chosen the best place to buy Trisalus Life Sciences stock, it's very important to research their stock before you buy, so you actually wrap your head around the risk as well as the upside.
Trisalus Life Sciences quick stats
Trisalus Life Sciences Due Diligence Checks
WallStreetZen was designed to help everyday investors do more in-depth fundamental analysis quickly.
You can view all of the due diligence checks on TLSI's stock page.
Is TLSI stock overvalued?
Investors use many financial metrics, analyses, models, and charts to gauge TLSI's fair value.
You can do additional valuation research on TLSI's stock here.
TLSI Financials at a glance
Passed Financial Due Diligence Checks:
- There are more short-term assets than short-term liabilities on the TLSI balance sheet.
Failed Financial Due Diligence Checks:
- TLSI has $8.53M in cash and short term investments. This is not sufficient to cover its annual cash burn of $41.19M.
- TLSI debt to equity ratio of -1.93 is negative.
- Total TLSI debt is still negative.
- TLSI has cash burn of 41188000. It does not have sufficient cash and short-term investments to cover this.
- TLSI profit margin has gone up by 2.19 percentage points in the past year, but the company is still unprofitable.
- There are more long-term liabilities than short-term assets on the TLSI balance sheet.
Is it a good time to buy TLSI stock, according to analysts?
Out of 3 Equities analysts who research TLSI, the consensus analyst rating on TLSI is a Strong Buy
It's important to note that analyst forecasts are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are saying on the Trisalus Life Sciences stock forecast page.
Metrics for Advanced TLSI Traders
Is TLSI Growing Revenue?
Last year, TLSI revenue was $29.43M. During the last three year, TLSI's revenue has increased by 135.78% per year. This was faster than the Medical Devices industry average of 9.91%.
Dive into TLSI's earnings and revenue performance here.
Are TLSI insiders buying or selling the stock?
Over the past 12 months, insiders at TLSI have bought more shares than they have sold.
James Emmett Young, Chief Financial Officer of TLSI, was the latest TLSI insider to buy. They bought $33,900.00 worth of TLSI stock on Feb 5, 2025.
Learn more about who owns TLSI stock here.
Does TLSI provide a stable income stream?
No, Trisalus Life Sciences doesn't provide an income stream by paying out dividends.
TLSI Social Trading Data
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Make your TLSI purchase
You have two primary options:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are generally the best for newer investors. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at an exact dollar amount, use a limit order.
Click the Open Trade button and eToro will place your order.
If you want more help buying stocks on eToro, watch the helpful video below:
Step 6: Get key alerts regarding your TLSI investment
Now that you own some TLSI shares, you'll want to stay up-to-date on your new shares.
Add TLSI to a watchlist to track the most important metrics related to your TLSI stock.
TLSI Feed
How to Buy Stock in Trisalus Life Sciences
To reiterate, here are the 6 steps for buying Trisalus Life Sciences stock:
- Decide where to buy Trisalus Life Sciences stock
- Create your brokerage account
- Put funds into your investment account
- Analyze Trisalus Life Sciences stock
- Make your TLSI purchase
- Get key alerts regarding your TLSI investment
If you require a place to buy stocks, eToro is our recommended option.
Get Started with eToro TodayIf you want to get updates on your investment in Trisalus Life Sciences, create a watchlist today.
Other Content You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.